"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SKIN.
| Descriptor ID |
D012878
|
| MeSH Number(s) |
C04.588.805 C17.800.882
|
| Concept/Terms |
Skin Neoplasms- Skin Neoplasms
- Neoplasms, Skin
- Neoplasm, Skin
- Skin Neoplasm
Cancer of Skin- Cancer of Skin
- Skin Cancers
- Cancer of the Skin
- Skin Cancer
- Cancer, Skin
- Cancers, Skin
|
Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".
This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 0 | 2 |
| 2005 | 3 | 0 | 3 |
| 2006 | 3 | 1 | 4 |
| 2007 | 2 | 0 | 2 |
| 2008 | 4 | 0 | 4 |
| 2009 | 3 | 1 | 4 |
| 2010 | 4 | 1 | 5 |
| 2011 | 7 | 0 | 7 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 3 | 6 |
| 2014 | 4 | 2 | 6 |
| 2015 | 6 | 1 | 7 |
| 2016 | 2 | 2 | 4 |
| 2017 | 6 | 0 | 6 |
| 2018 | 6 | 0 | 6 |
| 2019 | 7 | 0 | 7 |
| 2020 | 6 | 1 | 7 |
| 2021 | 11 | 0 | 11 |
| 2022 | 5 | 0 | 5 |
| 2023 | 3 | 0 | 3 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
The Utilization of PRAME in the Diagnosis, Prognosis, and Treatment of Melanoma. Cells. 2024 Oct 20; 13(20).
-
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications. Br J Cancer. 2024 Aug; 131(3):589-600.
-
Oral Mucosal Lentigo Maligna Treated With Mohs Micrographic Surgery. Dermatol Surg. 2023 May 01; 49(5):525-527.
-
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. N Engl J Med. 2023 Mar 02; 388(9):813-823.
-
Treatment of Trichilemmomas With Topical Sirolimus. JAMA Dermatol. 2023 03 01; 159(3):340-342.
-
Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series. Cancer Control. 2023 Jan-Dec; 30:10732748231155699.
-
Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity. Am J Hum Genet. 2022 Dec 01; 109(12):2210-2229.
-
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134. J Clin Oncol. 2023 01 10; 41(2):186-197.
-
Defining novel causal SNPs and linked phenotypes at melanoma-associated loci. Hum Mol Genet. 2022 08 25; 31(17):2845-2856.
-
Discrimination of cancerous from benign pigmented skin lesions based on multispectral autofluorescence lifetime imaging dermoscopy and machine learning. J Biomed Opt. 2022 06; 27(6).